Related Experiment Videos
[DF-2, a "new" gram-negative bacterium]
1Medizinische Universitätspoliklinik, Inselspital, Bern.
Abstract:
Dysgonic fermenter 2 (DF-2) is a long, fastidious gram negative rod that leads to life-threatening infections in immunocompromised and especially splenectomized patients. It can also severely affect the healthy individual. It is mainly acquired through contact with dogs and after dog bites. The infection has rarely been described, due to difficulties in isolating DF-2, its relatively low virulence, its susceptibility to antimicrobial agents and the frequent administration of antibiotics after animal bites. A systematic approach to the practical management of dog bite wounds is proposed.
Insights
Dysgonic fermenter 2 (DF-2) causes severe infections, particularly in immunocompromised individuals, often acquired through dog bites. Prompt management of dog bite wounds is crucial for preventing rare but serious DF-2 infections.
Area of Science:
- Microbiology
- Infectious Diseases
Context:
- Dysgonic fermenter 2 (DF-2) is a gram-negative bacterium associated with severe infections.
- Infections are primarily linked to dog bites and contact with dogs.
- DF-2 poses risks to both immunocompromised and healthy individuals.
Purpose:
- To highlight the clinical significance of DF-2 infections.
- To discuss the challenges in diagnosing and managing DF-2.
- To propose a systematic approach for managing dog bite wounds.
Summary:
- DF-2 is a fastidious bacterium causing life-threatening infections, especially in asplenic or immunocompromised patients.
- Despite its potential severity, DF-2 infections are rarely reported due to diagnostic challenges and antibiotic use post-bite.
- The study emphasizes the importance of recognizing DF-2 and outlines a management strategy for dog bite wounds.
Impact:
- Increases awareness of DF-2 as a potential pathogen in dog bite cases.
- Provides guidance for clinicians on managing animal bite wounds to prevent rare infections.
- Contributes to understanding the epidemiology and clinical presentation of DF-2 infections.